GENE ONLINE|News &
Opinion
Blog

2025-10-01|

ISTA Researchers Develop Method to Regulate Reactive Singlet Oxygen for Use in Biology and Renewable Energy

by Mark Chiang
Share To

Researchers at the Institute of Science and Technology Austria (ISTA) have developed a novel method to regulate singlet oxygen, a highly reactive form of oxygen. Singlet oxygen, known for its instability and reactivity, plays a significant role in various chemical processes but has posed challenges due to its unpredictable behavior. The findings are expected to impact multiple fields, including cellular biology, energy storage systems, and green hydrogen production.

The study focuses on the redox chemistry of oxygen and introduces an innovative approach to controlling singlet oxygen species. This advancement addresses longstanding difficulties associated with managing this reactive molecule. By improving control over singlet oxygen, scientists aim to enhance applications in biological research and renewable energy technologies. The discovery highlights potential pathways for optimizing chemical reactions involving singlet oxygen while mitigating risks tied to its reactivity. Researchers suggest that this breakthrough could pave the way for more efficient processes in areas such as sustainable energy solutions and advanced scientific studies.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: October 1, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Study Identifies Roles of CD46 and CD55 in Acute Lymphocytic and Myelogenous Leukemia
2026-01-13
LATEST
Study Identifies Roles of CD46 and CD55 in Acute Lymphocytic and Myelogenous Leukemia
2026-01-13
Jubilant Biosys Opens New Noida Facility to Double Early Chemistry Scale-Up Capacity
2026-01-13
Researchers Develop Precise DNA Rewriting Method for Mammalian Cells Using Programmable Tools
2026-01-13
Study Finds Limnospira indica Enhances Plant Growth and Alters Rhizosphere and Endosphere Microbial Communities
2026-01-13
Pharmaceutical Companies Urge FDA to Revise Post-Approval Change Rules to Facilitate US Manufacturing
2026-01-13
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Retired DEA Judge John Mulrooney and Attorney Andrew Hull to Present on Controlled Substances at January 2026 ACI Summit
2026-01-12
EVENT
2026-01-12
J.P. Morgan Healthcare Conference
San Francisco, California
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top